A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

SK-PC-B70M

dosage, frequency

Trial Locations (1)

Unknown

SKchemicalsI nvestigational Site, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT00443417 - A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter